Insufree drops in Brazil: Anvisa banned the P2 Brasil product

On 12 February 2026, Brazil’s health regulator Anvisa said it had ordered seizure and prohibited the sale, distribution, manufacture, advertising and use of Insufree drops, identified as a P2 Brasil Ltda. supplement, across all lots. The stated grounds were unknown origin, therapeutic directions and unapproved health claims on the label, plus a brand name suggesting a therapeutic effect. [1][2]

What Anvisa banned

This was not a clinical evaluation of a diabetes treatment. The notice does not report a laboratory finding of a hidden drug in Insufree, nor does it publish a complete ingredient list or doses. Keep the conclusion precise: Anvisa prohibited the P2 Brasil product it identified because of its unknown origin, labeling irregularities and improper therapeutic claims. [1][2]

What the Brazilian Diabetes Society debunked

The Brazilian Diabetes Society (SBD) separately described a fake webpage promising a natural, definitive cure for type 2 diabetes, inventing a researcher and attributing nonexistent interviews and endorsements to public figures. SBD said the page’s button led to a product called Insufree and that natural products are not indicated in diabetes guidelines as drug treatment. That finding concerns the promotional story SBD reviewed. [3]

What remains unproven

A matching name alone does not prove every Insufree offer is the P2 Brasil product, has the same formula or belongs to the banned lots. SBD’s article does not identify P2 Brasil as the manufacturer or prove that the product linked from the fake page was the same item in Anvisa’s order. We also found no verified evidence that buyers were pressured by phone into expensive courses.

What to do

• Do not buy or use the Insufree drops identified by Anvisa as the P2 Brasil product: the regulator prohibited all lots and use. [1][2]
• If you already bought it, keep the bottle, packaging, lot number and receipt, then speak with a doctor or pharmacist. Do not stop or replace prescribed diabetes medicines on your own. [1][4]
• Before trusting another product with the same name, verify its manufacturer, Brazilian company ID (CNPJ), lot, ingredients and regulatory status through Anvisa. A matching name or “natural” label proves neither identity, approval nor effectiveness. [4]
• Treat cure promises, advice to abandon treatment and pressure to pay immediately as warning signs. Ask for the total price, number of bottles and return terms in writing. Report irregular supplements to Anvisa. [3][4]

Our verdict

We do not recommend buying or using P2 Brasil’s Insufree drops: Anvisa prohibited all lots and use because the product’s origin was unknown and its therapeutic claims were irregular. A diabetes-cure promise is false and dangerous; SBD debunked a promotional story that directed readers to a product called Insufree. The sources do not prove every same-name offer is the same product or that anyone forced buyers into phone sales. Do not abandon prescribed care.